Viamet Pharmaceuticals has secured USD18m in a series B financing to accelerate the development of its metalloenzyme inhibitors and to advance its Metallophile Technology platform.

The European Commission’s Alternative Investment Fund Managers draft directive requires ‘major surgery’, according to Paul Myners, the UK Financial Services Secretary to the Treasury.

Somaxon Pharmaceuticals, a pharmaceutical company focused on the treatment of diseases and disorders in the central nervous system, has entered into a purchase agreement to issue and se

The Paul Green School of Rock Music has received a growth capital investment from Sterling Partners.

Qliance Medical Management, which operates insurance-free direct primary care clinics in Washington State, has closed a USD4m funding round from three institutional venture capital firm

OpenGate Capital, a global private equity firm, has sold its portfolio company, Global Star Solutions, to a management-led buyout team.

eCardio Diagnostics, a provider of arrhythmia monitoring services, it has received a minority investment from Sequoia Capital.

Prometheus Energy, a clean technology company, has closed private equity financing from Shell Technology Ventures Fund 1, managed by Kenda Capital.